ICCC
ImmuCell Corporation
10.00$
-0.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +859.2% | -111.2% | – | -131.8% | – | +463.4% | -27.5% | -261.8% | – | – | +591.6% | |
| – | +17.9% | +51.6% | +12.7% | +68.1% | +49.1% | +3.5% | +4.9% | +1.1% | +9.2% | -1.1% | +1.6% | |
| – | -22.6% | +190.2% | +196.4% | +72.2% | -9.0% | -19.2% | -43.0% | +84.5% | +38.5% | -11.6% | -9.2% | |
| – | – | -59.8% | -121.3% | – | +186.1% | -280.4% | – | +154,415.2% | – | – | – | |
| – | +324.6% | -723.3% | – | -43.2% | -462.0% | – | -404.8% | – | – | – | – | |
| – | +77.1% | +31.9% | +395.2% | -88.6% | -31.5% | +192.7% | -35.9% | +52.4% | -52.4% | -75.4% | +168.5% | |
| – | +200.8% | -4.3% | +177.5% | -85.4% | +89.7% | -24.5% | -37.8% | +148.2% | -52.3% | -75.6% | +163.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3,717.4% | +6,976.1% | -55.1% | -97.5% | +8,526.6% | -100.0% | – | – | – | – | – | |
| – | – | -108.0% | – | -86.6% | -271.6% | – | -118.7% | – | -99.8% | -180.9% | +0.7% | |
| – | – | +240.8% | +17.1% | -90.9% | +680.3% | -72.5% | +103.0% | -71.3% | +57.2% | +64.6% | -142.1% | |
| – | – | +394.5% | -137.8% | – | – | -82.6% | +392.7% | -235.8% | – | – | -98.3% | |
| – | – | -2,259.8% | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.